The emerging nanomedicine landscape

被引：1138

作者：

Wagner, Volker

Dullaart, Anwyn

Bock, Anne-Katrin

Zweck, Axel

机构：

[1] VDI Technol Zentrum GMBH, Assoc Gernab Ebgubeers, D-40239 Dusseldorf, Germany

[2] European Patent Off, NL-2288 EE Rijswijk, Netherlands

[3] Commiss European Communities, Joint Res Ctr, Inst Prospect Technol Studies, E-41092 Seville, Spain

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 10期

关键词：

D O I：

10.1038/nbt1006-1211

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry.

引用

页码：1211 / 1217

页数：7

共 9 条

[1] Drug delivery systems: Entering the mainstream [J].

Allen, TM ;

Cullis, PR .

SCIENCE, 2004, 303 (5665) :1818-1822

[2]

[Anonymous], 2005, NAN ESF EUR MED RES

[3]

DUNCAN R, 2000, ACS SYM SER, V752, P350

[4]

Duncan R., 2004, PHARM J, V273, P485

[5]

European Commission, 2005, NAN NAN ACT PLAN EUR

[6]

European Science and Technology Observatory, 2006, NAN MED SECT DRIV DE

[7] Developments in liposomal drug delivery systems [J].

Maurer, N ;

Fenske, DB ;

Cullis, PR .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (06) :923-947

[8] Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications [J].

Sato, M ;

Webster, TJ .

EXPERT REVIEW OF MEDICAL DEVICES, 2004, 1 (01) :105-114

[9]

The Royal Society & the Royal Academy of Engineering, 2004, NAN NAN OPP UNC

← 1 →